Larimar Therapeutics, Inc. (LRMR) vs Mobia Medical, Inc. Common Stock (MOBI)
A side-by-side comparison of Larimar Therapeutics, Inc. and Mobia Medical, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LRMR
Larimar Therapeutics, Inc.
$2.78HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
MOBI
Mobia Medical, Inc. Common Stock
$8.80HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — LRMR vs MOBI
growth of $100 · dividends reinvested · last 1yLRMR -27.4% (-27.4%/yr)MOBI -36.1% (-36.1%/yr)LRMR compounded faster over this window
LRMR MOBI
LRMR vs MOBI: by the numbers
- •MOBI is the larger company ($293M vs $289M market cap).
- •Both run net losses; LRMR's is the smaller (0.00% vs -145.12% net margin).
Metrics side by side
Valuation
| Metric | LRMR | MOBI |
|---|---|---|
| P/B ratio | 2.27 | 1.70 |
Profitability
| Metric | LRMR | MOBI |
|---|---|---|
| Gross margin | 0.00% | 81.07% |
| Operating margin | 0.00% | -144.71% |
| Net margin | 0.00% | -145.12% |
| ROE | -135.50% | N/A |
| ROIC | -136.49% | -122.21% |
Growth (annualized)
| Metric | LRMR | MOBI |
|---|---|---|
| Total return CAGR (5Y) | -23.91% | N/A |
Go deeper
Dig into the metrics
Larimar Therapeutics ROEMobia Medical, Inc. Common Stock ROELarimar Therapeutics operating marginMobia Medical, Inc. Common Stock operating marginLarimar Therapeutics revenue growthMobia Medical, Inc. Common Stock revenue growthLarimar Therapeutics free cash flowMobia Medical, Inc. Common Stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.